Quality generics from Zentiva

Featured News

Acquisition of Creo Pharmaceuticals Ltd. in the UK

April 1, 2019

Read more

Featured News

Zentiva and Siyiara Enterprises signed an agreement for the acquisition of Romanian pharma company, Solacium

March 13, 2019

Read more

Featured News

Nick Haggar appointed CEO of Zentiva

January 15, 2019

Read more

Featured News

Generics manufacturer Zentiva begins operations as independent company

October 1, 2018

Read more

Zentiva's key therapeutic areas:

  • Cardiovascular
  • Central nervous system
  • Gastrointestinal and metabolic disorders
  • Anti-inflammatory and pain
  • Ophthalmology
  • Anti-infectives
  • Urology
  • Respiratory

Other:

  • Blood disorders
  • Oncology
 

Zentiva is the third* largest and fast growing generics company in Europe.

Products

Learn about generics and pharmaceuticals

Careers

Work with us

Media

Stay up to date with the latest news
* IMS data (volume) 09/2016

Copyright Zentiva Group, a.s. © 2018

Last updated on: 4.2.2019